REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,830,025 | -50.1% | 712,072 | -4.6% | 0.11% | -47.6% |
| Q1 2024 | $3,671,004 | -44.9% | 746,139 | -1.6% | 0.21% | -45.6% |
| Q4 2023 | $6,663,242 | -15.1% | 758,048 | +10.8% | 0.39% | -22.5% |
| Q3 2023 | $7,844,757 | -43.9% | 683,937 | +23.8% | 0.50% | -37.3% |
| Q2 2023 | $13,983,655 | -46.3% | 552,495 | -31.7% | 0.79% | -46.4% |
| Q1 2023 | $26,063,559 | +61.3% | 809,176 | -7.6% | 1.48% | +59.8% |
| Q4 2022 | $16,161,656 | -33.2% | 875,496 | -2.4% | 0.93% | -34.0% |
| Q3 2022 | $24,212,000 | +61.4% | 896,754 | -17.4% | 1.40% | +93.7% |
| Q2 2022 | $14,999,000 | -30.8% | 1,085,340 | -2.4% | 0.72% | -16.1% |
| Q1 2022 | $21,690,000 | +19.3% | 1,112,325 | -0.1% | 0.86% | +34.0% |
| Q4 2021 | $18,180,000 | -29.1% | 1,113,945 | +21.1% | 0.64% | -31.9% |
| Q3 2021 | $25,625,000 | -6.6% | 919,760 | -0.7% | 0.95% | -3.0% |
| Q2 2021 | $27,443,000 | -11.3% | 925,890 | -16.3% | 0.98% | -3.2% |
| Q1 2021 | $30,928,000 | -2.7% | 1,106,547 | -1.3% | 1.01% | -9.8% |
| Q4 2020 | $31,773,000 | +11.8% | 1,121,152 | -0.8% | 1.12% | -2.4% |
| Q3 2020 | $28,409,000 | +12.6% | 1,130,016 | +9.4% | 1.14% | +5.7% |
| Q2 2020 | $25,233,000 | +65.5% | 1,033,279 | +0.3% | 1.08% | +27.1% |
| Q1 2020 | $15,248,000 | -11.9% | 1,030,281 | -3.4% | 0.85% | +45.6% |
| Q4 2019 | $17,303,000 | +23.4% | 1,066,128 | -1.2% | 0.58% | +16.8% |
| Q3 2019 | $14,023,000 | +22.5% | 1,078,697 | +22.2% | 0.50% | +31.8% |
| Q2 2019 | $11,450,000 | +520.6% | 882,769 | +654.1% | 0.38% | +544.1% |
| Q1 2019 | $1,845,000 | +176.2% | 117,068 | +252.7% | 0.06% | +145.8% |
| Q4 2018 | $668,000 | +10.2% | 33,193 | +36.2% | 0.02% | +9.1% |
| Q3 2018 | $606,000 | – | 24,372 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NQ HCIF GP, Ltd. | 3,096,650 | $52,457,000 | 100.00% |
| Essex Woodlands Management, Inc. | 4,592,047 | $77,789,000 | 24.28% |
| Rhenman & Partners Asset Management AB | 126,574 | $2,144,000 | 0.62% |
| Polar Capital LLP | 1,107,272 | $18,756,000 | 0.37% |
| ArrowMark Colorado Holdings LLC | 787,923 | $13,347,000 | 0.34% |
| Lombard Odier Asset Management (USA) Corp | 250,605 | $4,245,000 | 0.29% |
| Visium Asset Management, LP | 1,000,000 | $16,940,000 | 0.24% |
| C Partners Holding GmbH | 24,000 | $407,000 | 0.13% |
| NOTTINGHAM ADVISORS, INC. | 23,018 | $390,000 | 0.10% |
| WALL STREET ASSOCIATES | 57,330 | $971,000 | 0.09% |